SCHEMBL31661859

SCHEMBL31661859

Cc1ccc(C(=O)NCCCCCCCC(=O)O)c(O)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.55
EGLN1 Q9GZT9 1/20 0.52
POLB P06746 3/20 0.51
ALDH1A1 P00352 2/20 0.51
KDM4E B2RXH2 1/20 0.51
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
ALOX5 P09917 1/20 0.50
HDAC3 O15379 1/20 0.49
HDAC1 Q13547 1/20 0.49
PTGS1 P23219 1/20 0.49
PTGS2 P35354 1/20 0.49
APP P05067 3/20 0.49
NAAA Q02083 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
LMNA P02545 1/20 0.48
GAA P10253 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2915802 1.00 MAPK1 (0.55) MAPK1EGLN1POLBALDH1A1KDM4E
SCHEMBL31661686 0.89 NAAA (0.57) MAPK1POLBALDH1A1KDM4ENPC1
SCHEMBL2164508 0.89 NAAA (0.57) MAPK1POLBALDH1A1KDM4ENPC1
SCHEMBL5656378 0.86 MAPK1 (0.58) MAPK1POLBALDH1A1KDM4EALOX5
SCHEMBL11026787 0.86 MAPK1 (0.58) MAPK1POLBALDH1A1KDM4EALOX5
SCHEMBL13577934 0.84 NAAA (0.64) EGLN1ALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL12434386 0.84 POLB (0.63) MAPK1POLBALDH1A1NPC1RAB9A
SCHEMBL5654581 0.83 MAPK1 (0.55) MAPK1POLBALDH1A1KDM4EALOX5
SCHEMBL4624092 0.83 MAPK1 (0.55) MAPK1POLBALDH1A1KDM4EALOX5
SCHEMBL16545132 0.83 MAPK1 (0.55) MAPK1POLBALDH1A1KDM4EALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025151884-A1 USE OF GLYCOSAMINOGLYCAN SULFATED POLYSACCHARIDES SUCH AS SODIUM PENTOSAN POLYSULFATE IN COMBINATION WITH PERMEATION AGENTS TO TREAT ALZHEIMER'S DISEASE PARSONS C LOWELL (US) 2025-07-17 WO disclosed